Lead Discovery Center GmbH - Product Pipeline Review - 2016 - Global Markets Direct - Market Research

Lead Discovery Center GmbH - Product Pipeline Review - 2016

Lead Discovery Center GmbH - Product Pipeline Review - 2016 - Global Markets Direct - Market Research
Lead Discovery Center GmbH - Product Pipeline Review - 2016
Published Jul 27, 2016
76 pages — Published Jul 27, 2016
Price US$ 1,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Lead Discovery Center GmbH - Product Pipeline Review, 2016, provides an overview of the Lead Discovery Center GmbHs pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Lead Discovery Center GmbH, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Lead Discovery Center GmbH
- The report provides overview of Lead Discovery Center GmbH including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Lead Discovery Center GmbHs pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Lead Discovery Center GmbHs out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Lead Discovery Center GmbHs strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Lead Discovery Center GmbH
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Lead Discovery Center GmbHs pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  
Source:
Document ID
GMDHC08100CDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents26
  List of Tables71
  List of Figures71
Lead Discovery Center GmbH Snapshot81
  Lead Discovery Center GmbH Overview81
  Key Information81
  Key Facts81
Lead Discovery Center GmbH Research and Development Overview94
  Key Therapeutic Areas94
Lead Discovery Center GmbH Pipeline Review136
  Pipeline Products by Stage of Development131
  Pipeline Products Monotherapy141
  Pipeline Products Partnered Products151
    Partnered Products/Combination Treatment Modalities161
  Pipeline Products Out-Licensed Products171
    Out-Licensed Products/Combination Treatment Modalities181
Lead Discovery Center GmbH Pipeline Products Glance193
  Lead Discovery Center GmbH Early Stage Pipeline Products191
    Preclinical Products/Combination Treatment Modalities191
    Discovery Products/Combination Treatment Modalities202
Lead Discovery Center GmbH Drug Profiles2245
  Small Molecule for Target RhoGEF12 for Cardiovascular Disease221
    Product Description221
    Mechanism of Action221
    R&D Progress221
  Small Molecule to Activate Beclin1 for Neurodegenerative Diseases and Viral Infections231
    Product Description231
    Mechanism of Action231
    R&D Progress231
  Small Molecule to Inhibit FKBP51 for Anxiety and Major Depressive Disorder241
    Product Description241
    Mechanism of Action241
    R&D Progress241
  Small Molecules to Antagonize RON Kinase for Oncology251
    Product Description251
    Mechanism of Action251
    R&D Progress251
  Small Molecules to Inhibit Cyclophilin for Immunology and Respiratory Disorders261
    Product Description261
    Mechanism of Action261
    R&D Progress261
  englerin A271
    Product Description271
    Mechanism of Action271
    R&D Progress271
  Small Molecule 1 for Oncology281
    Product Description281
    Mechanism of Action281
    R&D Progress281
  Small Molecule 2 for Oncology291
    Product Description291
    Mechanism of Action291
    R&D Progress291
  Small Molecule 3 for Oncology301
    Product Description301
    Mechanism of Action301
    R&D Progress301
  Small Molecule 4 for Oncology311
    Product Description311
    Mechanism of Action311
    R&D Progress311
  Small Molecule for AMD, Inflammation and Oncology321
    Product Description321
    Mechanism of Action321
    R&D Progress321
  Small Molecule for Amyotrophic Lateral Sclerosis331
    Product Description331
    Mechanism of Action331
    R&D Progress331
  Small Molecule for Chlamydia Infections341
    Product Description341
    Mechanism of Action341
    R&D Progress341
  Small molecule for Multiple Sclerosis351
    Product Description351
    Mechanism of Action351
    R&D Progress351
  Small Molecule for Oncology361
    Product Description361
    Mechanism of Action361
    R&D Progress361
  Small Molecule to Activate TRIM32 for Neurodegenerative Diseases371
    Product Description371
    Mechanism of Action371
    R&D Progress371
  Small Molecule to Agonize P2Y6R for Type 2 Diabetes381
    Product Description381
    Mechanism of Action381
    R&D Progress381
  Small Molecule to Block TRPC4 and TRPC5 for Cardiovascular Disease and Epilepsy391
    Product Description391
    Mechanism of Action391
    R&D Progress391
  Small Molecule to Inhibit AML1/ETO for Acute Myeloid Leukemia401
    Product Description401
    Mechanism of Action401
    R&D Progress401
  Small Molecule to Inhibit CDK12 and CDK13 for Oncology411
    Product Description411
    Mechanism of Action411
    R&D Progress411
  Small Molecule to Inhibit Chemerin for Inflammation421
    Product Description421
    Mechanism of Action421
    R&D Progress421
  Small Molecule to Inhibit degS Serine Endoprotease for Bacterial Infections431
    Product Description431
    Mechanism of Action431
    R&D Progress431
  Small Molecule to Inhibit GLUT1 for Oncology441
    Product Description441
    Mechanism of Action441
    R&D Progress441
  Small Molecule to Inhibit GRK5 for Type 2 Diabetes451
    Product Description451
    Mechanism of Action451
    R&D Progress451
  Small Molecule to Inhibit MARK2 for Alzheimer's Disease461
    Product Description461
    Mechanism of Action461
    R&D Progress461
  Small Molecule to Inhibit Plexin-B1/Sema4D for Multiple Sclerosis and Osteoporosis471
    Product Description471
    Mechanism of Action471
    R&D Progress471
  Small Molecule to Inhibit RabGGTase for Solid Tumors481
    Product Description481
    Mechanism of Action481
    R&D Progress481
  Small Molecule to Inhibit SFRP1 for Oncology491
    Product Description491
    Mechanism of Action491
    R&D Progress491
  Small Molecule to Inhibit Steroid Sulfatase for Oncology501
    Product Description501
    Mechanism of Action501
    R&D Progress501
  Small Molecule to Target Draxin for Oncology511
    Product Description511
    Mechanism of Action511
    R&D Progress511
  Small Molecule to Target Hedgehog Pathway for Oncology521
    Product Description521
    Mechanism of Action521
    R&D Progress521
  Small Molecule to Target K-Ras/PDE Delta for Oncology531
    Product Description531
    Mechanism of Action531
    R&D Progress531
  Small Molecule to Target Nrg1-ErbB4 Pathway for Schizophrenia and Cardiovascular Diseases541
    Product Description541
    Mechanism of Action541
    R&D Progress541
  Small Molecule to Target SLC6A15 for Major Depressive Disorder551
    Product Description551
    Mechanism of Action551
    R&D Progress551
  Small Molecules 1 for Oncology561
    Product Description561
    Mechanism of Action561
    R&D Progress561
  Small Molecules for Charcot-Marie-Tooth Disease Type I A571
    Product Description571
    Mechanism of Action571
    R&D Progress571
  Small Molecules for Influenza581
    Product Description581
    Mechanism of Action581
    R&D Progress581
  Small Molecules for Lung Cancer591
    Product Description591
    Mechanism of Action591
    R&D Progress591
  Small Molecules for Oncology601
    Product Description601
    Mechanism of Action601
    R&D Progress601
  Small Molecules to Activate GFAT for Alzheimer s Disease611
    Product Description611
    Mechanism of Action611
    R&D Progress611
  Small Molecules to Agonize GPR81 for Atherosclerosis and Obesity621
    Product Description621
    Mechanism of Action621
    R&D Progress621
  Small Molecules to Inhibit LRRK2 for Parkinson's Disease631
    Product Description631
    Mechanism of Action631
    R&D Progress631
  Small Molecules to Inhibit NET Formation for Sepsis and SLE641
    Product Description641
    Mechanism of Action641
    R&D Progress641
  Small Molecules to Target Notch Signaling Pathway for Oncology651
    Product Description651
    Mechanism of Action651
    R&D Progress651
  Small Molecules to Target SIRT7 for Cardiovacular Diseases, Metabolic Syndrome and Oncology661
    Product Description661
    Mechanism of Action661
    R&D Progress661
Lead Discovery Center GmbH Pipeline Analysis675
  Lead Discovery Center GmbH Pipeline Products by Target672
  Lead Discovery Center GmbH Pipeline Products by Molecule Type691
  Lead Discovery Center GmbH Pipeline Products by Mechanism of Action702
Lead Discovery Center GmbH Recent Pipeline Updates721
Lead Discovery Center GmbH Dormant Projects731
Lead Discovery Center GmbH Locations And Subsidiaries741
  Head Office741
Appendix752
  Methodology751
  Coverage751
  Secondary Research751
  Primary Research751
  Expert Panel Validation751
  Contact Us751
  Disclaimer761

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Lead Discovery Center GmbH - Product Pipeline Review - 2016" Jul 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Lead-Discovery-Center-GmbH-Product-Pipeline-Review-2016-2088-16208>
  
APA:
Global Markets Direct - Market Research. (2016). Lead Discovery Center GmbH - Product Pipeline Review - 2016 Jul 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Lead-Discovery-Center-GmbH-Product-Pipeline-Review-2016-2088-16208>
  
US$ 1,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.